William Lea

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Contrast Medium-Induced Acute Kidney Injury

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases

Diminished Cardiac Fibrosis in Heart Failure is Associated with Altered Ventricular Arrhythmia Phenotype

Spironolactone Therapy is Associated with Reduced Ventricular Tachycardia Rate in Patients with Cardiomyopathy

The effect of RAAS blockade on the progression of diabetic nephropathy

The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases

Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore

Synthesis, Biological Evaluation, and Molecular Modeling of 1-Benzyl-1H-imidazoles as Selective Inhibitors of Aldosterone Synthase (CYP11B2)

Fibrosis — A Common Pathway to Organ Injury and Failure

Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency

Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt